Nov. 16 (Bloomberg) -- Bayer AG, Germany’s largest drugmaker, Novartis AG and Sanofi-Aventis SA were rated “buy” in new coverage at Deutsche Bank AG, which said “each of which has the potential for material forecast upgrades.”

Last Updated: November 16, 2009 01:02 EST